QXO vs. NOVO-B.CO

Last updated Jun 9, 2026

QXO (QXO, Inc) and NOVO-B.CO (Novo Nordisk A/S) are both stocks. QXO operates in Software - Application (Technology), while NOVO-B.CO operates in Biotechnology (Healthcare). Over the past 10 years, QXO returned 7.76%/yr vs 16.29%/yr for NOVO-B.CO. At a 0.05 correlation, their price movements are largely independent.

Performance

QXO vs. NOVO-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in QXO, Inc (QXO) and Novo Nordisk A/S (NOVO-B.CO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

QXO is traded in USD, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, QXO achieves a -19.44% return, which is significantly lower than NOVO-B.CO's -14.86% return. Over the past 10 years, QXO has underperformed NOVO-B.CO with an annualized return of 7.76%, while NOVO-B.CO has yielded a comparatively higher 16.29% annualized return.

QXO

• 1D: -1.40%
• 1M: -17.16%
• YTD: -19.44%
• 6M: -26.94%
• 1Y: -18.21%
• 3Y*: -7.59%
• 5Y*: -19.91%
• 10Y*: 7.76%

NOVO-B.CO

• 1D: 0.00%
• 1M: -8.03%
• YTD: -14.86%
• 6M: -6.49%
• 1Y: -41.18%
• 3Y*: 5.14%
• 5Y*: 18.06%
• 10Y*: 16.29%

*Multi-year figures are annualized to reflect compound growth (CAGR)

QXO vs. NOVO-B.CO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
QXO QXO, Inc	-19.44%	21.32%	-86.06%	508.46%	-33.78%	63.72%	-17.22%	92.05%	-45.15%	43.66%
NOVO-B.CO Novo Nordisk A/S	-14.86%	-39.54%	-15.04%	214.95%	23.90%	65.39%	27.16%	32.88%	-10.64%	58.82%

Correlation

The correlation between QXO and NOVO-B.CO is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.06
Correlation (5Y) Calculated over the trailing 5-year period	0.08
Correlation (10Y) Calculated over the trailing 10-year period	0.06
Correlation (All Time) Calculated using the full available price history since Mar 15, 2012	0.05

The correlation between QXO and NOVO-B.CO shifts across timeframes, from 0.05 (all time) to 0.16 (1 year), reflecting how their relationship changes across market environments.

Return for Risk

QXO vs. NOVO-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QXO

QXO Risk / Return Rank: 28
QXO Sharpe Ratio Rank: 29
QXO Sortino Ratio Rank: 29
QXO Omega Ratio Rank: 29
QXO Calmar Ratio Rank: 28
QXO Martin Ratio Rank: 25

NOVO-B.CO

NOVO-B.CO Risk / Return Rank: 13
NOVO-B.CO Sharpe Ratio Rank: 10
NOVO-B.CO Sortino Ratio Rank: 13
NOVO-B.CO Omega Ratio Rank: 12
NOVO-B.CO Calmar Ratio Rank: 12
NOVO-B.CO Martin Ratio Rank: 17

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QXO vs. NOVO-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for QXO, Inc (QXO) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	QXO	NOVO-B.CO	Difference
Sharpe ratio: Return per unit of total volatility	-0.31	-0.75	+0.44
Sortino ratio: Return per unit of downside risk	-0.09	-0.84	+0.75
Omega ratio: Gain probability vs. loss probability	0.99	0.88	+0.11
Calmar ratio: Return relative to maximum drawdown	-0.43	-0.76	+0.33
Martin ratio: Return relative to average drawdown	-0.90	-1.14	+0.24
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

QXO vs. NOVO-B.CO - Sharpe Ratio Comparison

The current QXO Sharpe Ratio is -0.31, which is higher than the NOVO-B.CO Sharpe Ratio of -0.75. The chart below compares the historical Sharpe Ratios of QXO and NOVO-B.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	QXO	NOVO-B.CO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.31	-0.75	+0.44
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.14	0.31	-0.45
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.06	0.36	-0.30
Sharpe Ratio (All Time) Calculated using the full available price history	0.05	0.66	-0.61

Drawdowns

QXO vs. NOVO-B.CO - Drawdown Comparison

The maximum QXO drawdown since its inception was -95.44%, which is greater than NOVO-B.CO's maximum drawdown of -74.86%. Use the drawdown chart below to compare losses from any high point for QXO and NOVO-B.CO.

Drawdown Indicators

	QXO	NOVO-B.CO	Difference
Max Drawdown Largest peak-to-trough decline	-95.44%	-74.86%	-20.58%
Max Drawdown (1Y) Largest decline over 1 year	-42.59%	-54.88%	+12.29%
Max Drawdown (3Y) Largest decline over 3 years	-95.44%	-74.86%	-20.58%
Max Drawdown (5Y) Largest decline over 5 years	-95.44%	-74.86%	-20.58%
Max Drawdown (10Y) Largest decline over 10 years	-95.44%	-74.86%	-20.58%
Current Drawdown Current decline from peak	-93.40%	-69.56%	-23.84%
Average Drawdown Average peak-to-trough decline	-56.37%	-12.33%	-44.04%
Ulcer Index Depth and duration of drawdowns from previous peaks	20.33%	36.42%	-16.09%

Volatility

QXO vs. NOVO-B.CO - Volatility Comparison

QXO, Inc (QXO) has a higher volatility of 14.68% compared to Novo Nordisk A/S (NOVO-B.CO) at 11.16%. This indicates that QXO's price experiences larger fluctuations and is considered to be riskier than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	QXO	NOVO-B.CO	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.68%	11.16%	+3.52%
Volatility (6M) Calculated over the trailing 6-month period	46.00%	40.40%	+5.60%
Volatility (1Y) Calculated over the trailing 1-year period	58.69%	55.90%	+2.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	145.36%	58.91%	+86.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	123.58%	45.47%	+78.11%

Dividends

QXO vs. NOVO-B.CO - Dividend Comparison

QXO has not paid dividends to shareholders, while NOVO-B.CO's dividend yield for the trailing twelve months is around 4.35%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NOVO-B.CO Novo Nordisk A/S	4.35%	3.58%	1.59%	1.01%	2.38%	2.54%	4.03%	4.22%	5.27%	4.54%	7.38%	2.50%
QXO QXO, Inc	0.00%	0.00%	164.53%	1.17%	0.00%	13.42%	31.47%	1.15%	0.00%	1.89%	2.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both QXO and NOVO-B.CO in my portfolio?

QXO and NOVO-B.CO have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.